๐ฌIn plain words
What the trial is, and whether it could suit you
The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* The investigators enrolled individuals of both genders, aged between 18 and 75,
* All patients had acute first-ever embolic ischemic stroke and were eligible for thrombolysis.
* All patients had Atrial fibrillation
Exclusion Criteria:
* The investigators excluded patients who had alteplase contraindications
* The investigators excluded patients who did not receive the total dose of alteplase for any reason.
* The investigators excluded patients who had a known history of persistent or recurrent CNS pathology (e.g., epilepsy, meningioma, multiple sclerosis)
* The investigators excluded patients who had recurrent ischemic stroke diagnosed by appropriate clinical history and/or MRI brain findings.
* The investigators excluded patients with symptoms of major organ failure, active malignancies, or an acute myocardial infarction within the previous six weeks.
* The investigators also excluded pregnant and lactating patients with stroke due to venous thrombosis and stroke following cardiac arrest.
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt
๐ค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ always decide together with your own doctor.